This assessment reveals key parameters impacting outcomes in COVID-19-related ARDS patients, highlighting critical risk factors.
It has been understood that in 2019, coronavirus disease 2019 (COVID-19), believed to have originated in the city of Wuhan, China, and caused by the coronavirus, has a wide range of disease potential, from asymptomatic cases to acute respiratory distress syndrome (ARDS). Some risk factors have been identified for COVID-19-related ARDS (CARDS) patients. These risk factors include old age, the presence of chronic diseases, male gender, and smoking. During the monitoring of patients in intensive care units, there are significant changes in clinical findings, vital signs, and some laboratory findings, especially. Currently, there is still no specific treatment available for both COVID-19 and CARDS.
No takes yet. Share an insight, caveat, or question.
Yıldız et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: